Psychosis as a multisystem disorder of aberrant aging.
Abstract
Psychotic disorders, including schizophrenia and affective psychosis, affect ~3% of the population and typically emerge in early adulthood. Cardiometabolic disease accounts for much of the 20-year life-expectancy gap in psychosis. Evidence indicates potentially causal processes, often seen in aging, act within and beyond the brain, and before the onset of treatment; these include inflammation, metabolic and mitochondrial dysfunction. Here we synthesize evidence and propose a framework that proposes psychosis as a multisystem disorder of accelerated aging, and outline implications for aging-targeted interventions.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper proposes that psychosis is a multisystem disorder characterized by accelerated aging processes. This research is relevant as it explores the underlying mechanisms of psychosis that may relate to aging, potentially informing interventions that target aging-related pathways.
Author of this paper? Send a correction.